Effects of androgen deprivation on brain function in prostate cancer patients - a prospective observational cohort analysis

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Chao, Herta H ^a,b   Uchio, Edward ^c   Zhang, Sheng ^d   Hu, Sien ^d   Bednarski, Sarah R ^d   Luo, Xi ^e   Rose, Michal ^a,b   Concato, John ^a,b   Li, Chiang shan R ^d,f  

^a YALE CANCER CENTER   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c Tower Research ^*  (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BROWN UNIVERSITY   (United States)

^f YALE UNIVERSITY   (United States)

Author keywords

Androgen deprivation; Brain function; Cognitive function; Prostate cancer

Indexed keywords

ANDROGEN; BICALUTAMIDE; GOSERELIN;

AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BRAIN FUNCTION; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LONG TERM CARE; MALE; NEUROPSYCHOLOGICAL TEST; OBSERVATIONAL STUDY; PREFRONTAL CORTEX; PROSPECTIVE STUDY; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; TASK PERFORMANCE; WORKING MEMORY;

AGED; ANDROGEN ANTAGONISTS; ANILIDES; ANTINEOPLASTIC AGENTS, HORMONAL; BRAIN; COGNITION; COHORT STUDIES; GOSERELIN; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NITRILES; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; PSYCHOMOTOR PERFORMANCE; QUALITY OF LIFE; QUESTIONNAIRES; TOSYL COMPOUNDS; TREATMENT OUTCOME;

EID: 84865326377     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-371     Document Type: Article

References (47)

1. Meng MV, Grossfeld GD, Sadetsky N, Mehta SS, Lubeck DP, Carroll PR. Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer. Urology 2002, 60(Suppl 3A):7-12.
2. Shahinian VB, Kuo Y-F, Freeman JL, Orihuela E, Goodwin JS. Increasing use of gonadotropin-releasing hormone agonists for localized prostate cancer. Cancer 2005, 103:1615-1624. 10.1002/cncr.20955, 15742331.
3. Alibhai SM, Gogov S, Allibhai Z. Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review. Crit Rev Oncol Hematol 2006, 60:201-215. 10.1016/j.critrevonc.2006.06.006, 16860998.
4. Moffat SD, Zonderman AB, Metter EJ, Kawas C, Blackman MR, Harman SM, Resnick SM. Free testosterone and risk for Alzheimer disease in older men. Neurology 2004, 62:188-193. 10.1212/WNL.62.2.188, 14745052.
5. Kenny AM, Fabregas G, Song C, Biskup B, Bellantonio S. Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss. J Gerontol A Biol Sci Med Sci 2004, 59:75-78. 10.1093/gerona/59.1.M75, 14718489.
6. Cherrier MM, Matsumoto AM, Amory JK, Johnson M, Craft S, Peskind ER, Raskind MA. Characterization of verbal and spatial memory changes from moderate to supraphysiological increases in serum testosterone in healthy older men. Psychoneuroendocrinology 2007, 32:72-79. 10.1016/j.psyneuen.2006.10.008, 1864939, 17145137.
7. Cherrier MM, Matsumoto AM, Amory JK, Asthana S, Bremner W, Peskind ER, Raskind MA, Craft S. Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment. Neurology 2005, 64:2063-2068. 10.1212/01.WNL.0000165995.98986.F1, 15985573.
8. Lu PH, Masterman DA, Mulnard R, Cotman C, Miller B, Yaffe K, Reback E, Porter V, Swerdloff R, Cummings JL. Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men. Arch Neurol 2006, 63:177-185. 10.1001/archneur.63.2.nct50002, 16344336.
9. Nelson CJ, Lee JS, Gamboa MC, Roth AJ. Cognitive effects of hormone therapy in men with prostate cancer: a review. Cancer 2008, 113(5):1097-1106. 10.1002/cncr.23658, 18666210.
10. Joly F, Alibhai SM, Galica J, Park A, Yi QL, Wagner L, Tannock IF. Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer. J Urol 2006, 176:2443-2447. 10.1016/j.juro.2006.07.151, 17085125.
11. Almeida OP, Waterreus A, Spry N, Flicker L, Martins RN. One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology 2004, 29:1071-1081. 10.1016/j.psyneuen.2003.11.002, 15219659.
12. Green HJ, Pakenham KI, Headley BC, Yaxley J, Nicol DL, Mactaggart PN, Swanson C, Watson RB, Gardiner RA. Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial. BJU Int 2002, 90:427-432. 10.1046/j.1464-410X.2002.02917.x, 12175403.
13. Jenkins VA, Bloomfield DJ, Shilling VM, Edginton TL. Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study. BJU Int 2005, 96:48-53. 10.1111/j.1464-410X.2005.05565.x, 15963119.
14. Salminen E, Portin R, Korpela J, et al. Androgen deprivation and cognition in prostate cancer. Br J Cancer 2004, 89:971-976.
15. Miller SP, McQuillen PS. Neurology of congenital heart disease: insight from brain imaging. Arch Dis Child Fetal Neonatal Ed 2007, 92:F435-F437. 10.1136/adc.2006.108845, 2675385, 17848505.
16. Korzeniewski SJ, Birbeck G, DeLano MC, Potchen MJ, Paneth N. A systematic review of neuroimaging for cerebral palsy. J Child Neurol 2008, 23:216-227.
17. Tan HY, Sust S, Buckholtz JW, Mattay VS, Meyer-Lindenberg A, Egan MF, Weinberger DR, Callicott JH. Dysfunctional prefrontal regional specialization and compensation in schizophrenia. Am J Psychiatry 2006, 163:1969-1977. 10.1176/appi.ajp.163.11.1969, 17074949.
18. Driesen NR, Leung HC, Calhoun VD, Constable RT, Gueorguieva R, Hoffman R, Skudlarski P, Goldman-Rakic PS, Krystal JH. Impairment of Working Memory Maintenance and Response in Schizophrenia: Functional Magnetic Resonance Imaging Evidence. Biol Psychiatry 2008, 64:1026-1034. 10.1016/j.biopsych.2008.07.029, 2650279, 18823880.
19. Koch K, Wagner G, Nenadic I, Schachtzabel C, Schultz C, Roebel M, Reichenbach JR, Sauer H, Schlosser RG. Fronto-striatal hypoactivation during correct information retrieval in patients with schizophrenia: an fMRI study. Neuroscience 2008, 153:54-62. 10.1016/j.neuroscience.2008.01.063, 18359576.
20. Castellon SA, Silverman DH, Ganz PA. Breast cancer treatment and cognitive functioning: current status and future challenges in assessment. Breast Cancer Res Treat 2005, 92:199-206. 10.1007/s10549-005-5342-0, 16155790.
21. Silverman DH, Dy CJ, Castellon SA, Lai J, Pio BS, Abraham L, Waddell K, Petersen L, Phelps ME, Ganz PA. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat 2007, 103(3):303-311. 10.1007/s10549-006-9380-z, 17009108.
22. Ferguson RJ, McDonald BC, Saykin AJ, Ahles TA. Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. J Clin Oncol 2007, 25(25):3866-3870. 10.1200/JCO.2007.10.8639, 3329758, 17761972.
23. Eberling JL, Wu C, Tong-Turnbeaugh R, Jagust WJ. Estrogen- and tamoxifen-associated effects on brain structure and function. NeuroImage 2004, 21:364-371. 10.1016/j.neuroimage.2003.08.037, 14741674.
24. Deprez S, Amant F, Smeets A, Peeters R, Leemans A, Van Hecke W, Verhoeven JS, Christiaens MR, Vandenberghe J, Vandenbulcke M, Sunaert S. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol 2012, 30(3):274-281. Epub 2011 Dec 19, 10.1200/JCO.2011.36.8571, 22184379.
25. Kesler SR, Kent JS, O''Hara R. Prefrontal cortex and executive function impairments in primary breast cancer. Arch Neurol 2011, 68(11):1447-1453. 10.1001/archneurol.2011.245, 3239218, 22084128.
26. Folstein MF, Folstein SE, McHugh PR. " Mini-mental state" . A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198. 10.1016/0022-3956(75)90026-6, 1202204.
27. First MB, Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-IV (SCID) 1995, Washington DC: American Psychiatric Association.
28. Esper P, Mo F, Chodak G, Sinner M, Cella D, Pienta KJ. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology 1997, 50:920-928. 10.1016/S0090-4295(97)00459-7, 9426724.
29. Baddeley A. Working memory: looking back and looking forward. Nature Reviews. Neuroscience 2003, 4:829-839.
30. Kirchner WK. Age differences in short-term retention of rapidly changing information. J Exp Psychol 1958, 55:352-358.
31. Logan GD, Cowan WB, Davis KA. On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol Hum Percept Perform 1984, 10:276-291.
32. Li C-SR, Chao HH-A, Lee TW. The neural correlates of speeded compared to delayed responses in a stop signal task: an indirect analogue of risk taking and association with an anxiety trait. Cerebral Cortex 2009, 19:839-848. 2722793, 18678764.
33. Chao HH, Luo X, Chang JL, Li CS. Activation of the pre-supplementary motor area but not inferior prefrontal cortex in association with short stop signal reaction time-an intra-subject analysis. BMC Neurosci 2009, 10:75. 10.1186/1471-2202-10-75, 2719646, 19602259.
34. Ridderinkhof KR, van den Wildenberg WP, Segalowitz SJ, Carter CS. Neurocognitive mechanisms of cognitive control: the role of prefrontal cortex in action selection, response inhibition, performance monitoring, and reward-based learning. Brain Cogn 2004, 56:129-140. 10.1016/j.bandc.2004.09.016, 15518930.
35. Rushworth MF. Intention, choice, and the medial frontal cortex. Ann N Y Acad Sci 2008, 1124:181-207. 10.1196/annals.1440.014, 18400931.
36. Li CS, Morgan PT, Matuskey D, Abdelghany O, Luo X, Chang JL, Rounsaville BJ, Ding YS, Malison RT. Biological markers of the effects of intravenous methylphenidate on improving inhibitory control in cocaine-dependent patients. Proc Natl Acad Sci U S A 2010, 107:14455-14459. 10.1073/pnas.1002467107, 2922598, 20660731.
37. Cohen J. Statistical Power Analysis for the Behavioral Sciences (second edition) 1988, Hillsdale, New Jersey: Lawrence Erlbaum Associates.
38. Brett M, Anton J-L, Valabregue R, Poline J-P. Region of interest analysis using an SPM toolbox. Abstract presented at the 8th International Conference on Functional Mapping of the Human Brain. June 2--6 2002, Sendai, Japan, Available on CD-ROM in Neuro-Image, 16(2), abstract 497.
39. Fair DA, Schlaggar BL, Cohen AL, Miezin FM, Dosenbach NU, Wenger KK, Fox MD, Snyder AZ, Raichle ME, Petersen SE. A method for using blocked and event-related fMRI data to study "resting state" functional connectivity. NeuroImage 2007, 35:396-405. 10.1016/j.neuroimage.2006.11.051, 2563954, 17239622.
40. Fox MD, Raichle ME. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci 2007, 8:700-711. 10.1038/nrn2201, 17704812.
41. Alibhai SM, Breunis H, Timilshina N, Marzouk S, Stewart D, Tannock I, Naglie G, Tomlinson G, Fleshner N, Krahn M, Warde P, Canning SD. Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancer. J Clin Oncol 2010, 28(34):5030-5037. 10.1200/JCO.2010.30.8742, 21041708.
42. Azad N, Pitale S, Barnes WE, Friedman N. Testosterone treatment enhances regional brain perfusion in hypogonadal men. J Clin Endocrinol Metab 2003, 88:3064-3068. 10.1210/jc.2002-020632, 12843144.
43. Forbes EE, Ryan ND, Phillips ML, Manuck SB, Worthman CM, Moyles DL, Tarr JA, Sciarrillo SR, Dahl RE. Healthy adolescents' neural response to reward: associations with puberty, positive affect, and depressive symptoms. J Am Acad Child Adolesc Psychiatry 2010, 49:162-72.e1-5. 2837556, 20215938.
44. Hermans EJ, Bos PA, Ossewaarde L, Ramsey NF, Fernández G, van Honk J. Effects of exogenous testosterone on the ventral striatal BOLD response during reward anticipation in healthy women. NeuroImage 2010, 52:277-283. 10.1016/j.neuroimage.2010.04.019, 20398773.
45. Moffat SD, Resnick SM. Long-term measures of free testosterone predict regional cerebral blood flow patterns in elderly men. Neurobiol Aging 2007, 28:914-920. 10.1016/j.neurobiolaging.2006.04.001, 16698125.
46. van Wingen GA, Zylicz SA, Pieters S, Mattern C, Verkes RJ, Buitelaar JK, Fernández G. Testosterone increases amygdala reactivity in middle-aged women to a young adulthood level. Neuropsychopharmacology 2009, 34:539-547. 10.1038/npp.2008.2, 18235425.
47. Cherrier MM, Borghesani PR, Shelton AL, Higano CS. Changes in neuronal activation patterns in response to androgen deprivation therapy: a pilot study. BMC Cancer 2010, 10:1. 10.1186/1471-2407-10-1, 2824708, 20047689.